← Back to patent-cliff list
Ciclosporin Eye Drops(CZhuhai Essex Bio-Pharma)
Tier C — Watch / tradeCiclosporin Eye Drops(CZhuhai Essex Bio-Pharma)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Calcineurin, Mitocliondrial permeability transition pore, PGY1
Indications (approved)：Dry eye disease
Regional status
US
-
EU
-
China
Phase II
2023-03-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ciclosporin Eye Drops(CZhuhai Essex Bio-Pharma)?
Approved indications include: Dry eye disease.
When does the Ciclosporin Eye Drops(CZhuhai Essex Bio-Pharma) patent expire?
No public expiry year is available for Ciclosporin Eye Drops(CZhuhai Essex Bio-Pharma) yet; this page updates once verified.
How do I get a quote for Ciclosporin Eye Drops(CZhuhai Essex Bio-Pharma) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03